Nutrient injection · reference only
Lipo-C
Lipo-C is a name used for compounded nutrient injections, not a peptide or a single standardized formula. Ingredients and strengths depend on the pharmacy.
What’s in Lipo-C?
One documented example: MediVera’s product-specification section lists the following concentrations in a prepared injection solution. MediVera ↗
Concentration · not a dose
- Methionine
- 15 mg/mL
- Choline
- 50 mg/mL
- Carnitine
- 50 mg/mL
- Dexpanthenol
- 5 mg/mL
Listed vial volumes: 10 / 30 mL
Formula check: the same page’s introduction mentions inositol, but its product specifications do not. Do not assume every Lipo-C or MIC product has the same ingredients; confirm the actual label, chemical forms and concentrations.
What the evidence actually supports
- Carnitine helps transport long-chain fatty acids into mitochondria. A biological role in energy production is not proof that Lipo-C injections cause weight loss.
- NIH reviews mixed weight-loss findings for carnitine supplements and calls for larger studies. Those studies do not establish results for this multi-ingredient injection.
- MediVera acknowledges no current studies of its methionine–choline–carnitine–dexpanthenol combination. Its product page is a pharmacy source, not a clinical trial.
Community protocols: what’s verified?
MediVera publishes practice-reported injection schedules but explicitly states there are no approved dosages or regimens for Lipo-C. These are pharmacy-reported practices, not independently validated community protocols. We have not established a universal evidence-based schedule.
No dosing or titration schedule is reproduced here. A volume alone cannot describe ingredient exposure when formulas differ. Do not transfer instructions between products or use a powder reconstitution chart for this prepared liquid.
Safety & handling
Compounded drugs are not FDA-approved. FDA does not verify their safety, effectiveness or quality before marketing; poor compounding can cause contamination or incorrect strength.
Safety & handling
Compounded drugs are not FDA-approved. FDA does not verify their safety, effectiveness or quality before marketing; poor compounding can cause contamination or incorrect strength.
- Compounded drugs are not FDA-approved. FDA does not verify their safety, effectiveness or quality before marketing; poor compounding can cause contamination or incorrect strength.
- MediVera reports injection-site discomfort, swelling or nodules, nausea, diarrhea, dizziness, fishy odor and headache. This is not a comprehensive, trial-derived risk list for every Lipo-C formulation.
- Storage and beyond-use dates are product-specific. Check the dispensing label and pharmacist’s instructions rather than applying a generic shelf life. Persistent or severe reactions require medical assessment.
Sources & provenance
Pharmacy product information
MediVera Compounding Pharmacy. Lipo-C Injection. ↗Regulatory source
FDA. Compounding and the FDA: Questions and Answers. ↗Ingredient evidence review
NIH Office of Dietary Supplements. Carnitine — Health Professional Fact Sheet. ↗
Research use only. This information is not a prescription, an endorsement or instructions for human use. Prescription-compounded products are distinct from research-market materials.